Innovative Pilot Program Supports Cancer Survivors in Workforce Reintegration

A new pilot project spearheaded by researchers at McGill University has demonstrated early success in facilitating the return of cancer survivors to the workforce. This initiative, named iCanWork, addresses a critical but often overlooked aspect of recovery—employment. Christine Maheu, an Associate Professor at McGill's Ingram School of Nursing, is leading the effort in collaboration with BC Cancer. The project aims to provide cancer survivors with the necessary support to re-enter the job market, which is frequently neglected in cancer care plans.

Employment is not typically regarded as a key health indicator in cancer treatment, despite its significant impact on survivors' quality of life from the moment of diagnosis. According to Dr. Maheu, "Work is associated with better quality of life in survivors, yet the lingering side effects of cancer treatments, such as fatigue and anxiety, complicate their ability to return to work."

The iCanWork program is a 10-step online support initiative that includes virtual meetings with return-to-work counselors and therapists who help participants navigate the challenges of reintegration. In a randomized trial involving 24 cancer survivors, the program yielded promising results: 50% of participants returned to full-time employment within three months, compared to only one-third in the control group. Participants also reported improvements in work effectiveness and social connectivity, while pain interference in daily activities decreased.

One participant remarked that without the guidance of the program, she would have considered quitting her job, while another had contemplated early retirement but decided to revise her plans thanks to the support received.

This groundbreaking program aims to fill a significant gap in Canadian cancer care, where only 4% of employers have specific return-to-work policies for cancer survivors. Dr. Maheu emphasized the financial implications of this oversight, noting that cancer patients often incur over $2,500 monthly in lost wages and related expenses. In contrast, employers may spend up to $24,000 to replace an employee on medical leave.

"Proper support benefits both employees and employers," Dr. Maheu asserted. The research team is preparing for a larger trial and is actively seeking partners to expand the iCanWork program across Canada. Although the structured program tested in the study is still in development, survivors can already access various tools and resources via the Cancer and Work website, which has been recognized for its inclusive design since its launch in 2016.

In summary, the iCanWork project represents a significant advancement in addressing the needs of cancer survivors in the workplace, highlighting the importance of employment support in the recovery process and the potential benefits for both individuals and organizations. As the program evolves, its implications for the broader healthcare landscape and workplace policies could be profound, paving the way for more inclusive practices that support the reintegration of cancer survivors into the workforce.